Emyria Ltd has released a press release.
Emyria Secures Local MDMA to Start PTSD Trial Dosing
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- Emyria Completes Acquisition of the Pax Centre
- Emyria provides unique combination of drug development and therapy delivery
- Strategic Update & Entitlement Offer Presentation
- Prospectus
- Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer
Later from Emyria
- Emyria set to begin MDMA study after securing local supply
- Completion of Entitlement Offer
- Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone
- Health Canada Approval Received for MDMA Import
- September 2023 Quarterly Activities Report and Appendix 4C
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria